Literature DB >> 10623680

Clonality as expression of distinctive cell kinetics patterns in nodular hyperplasias and adenomas of the adrenal cortex.

S J Díaz-Cano1, M de Miguel, A Blanes, R Tashjian, H Galera, H J Wolfe.   

Abstract

Although histopathologic criteria for adrenal cortical nodular hyperplasias (ACNHs) and adenomas (ACAs) have been developed, their kinetics and clonality are virtually unknown. We studied 20 ACNHs and 25 ACAs (based on World Health Organization criteria) from 45 females. Representative samples were histologically evaluated, and the methylation pattern of the androgen receptor alleles was analyzed on microdissected samples. Consecutive sections were selected for slide cytometry, flow cytometry, and in situ end labeling (ISEL). Apoptosis was studied by flow cytometry (nuclear area/DNA content plotter analysis) and by ISEL. Appropriate tissue controls were run in every case. Polyclonal gel patterns were revealed in 14/18 informative ACNHs and in 3/22 informative ACAs, whereas monoclonal gel patterns were observed in 4/18 ACNHs and 19/22 ACAs. Overlapping proliferation rates (PRs) were observed in both clonal groups, and apoptosis was detected only in G(0)/G(1) cells, especially in monoclonal ACNHs (3/4; 75%) and in polyclonal ACAs (2/3; 67%). Significantly higher PRs were observed in ACNHs with polyclonal patterns and G(0)/G(1) apoptosis and in ACAs regardless of clonality pattern and presence of G(0)/G(1) apoptosis. All except one ACNH (19/20; 95%) and 15/25 ACAs (60%) showed diploid DNA content, whereas the remaining cases were hyperdiploid. A direct correlation between PR and ISEL was observed in polyclonal lesions (PR = 29.32 ISEL - 1.93), whereas the correlation was inverse for monoclonal lesions (PR = -9.13 ISEL + 21.57). We concluded that only simultaneous down-regulated apoptosis and high proliferation result in selective kinetic advantage, dominant clone expansion, and unbalanced methylation patterns of androgen receptor alleles in ACNHs and ACAs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623680      PMCID: PMC1868630          DOI: 10.1016/S0002-9440(10)64732-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

1.  Some milestones in the history of X-chromosome inactivation.

Authors:  M F Lyon
Journal:  Annu Rev Genet       Date:  1992       Impact factor: 16.830

2.  DNA extraction from formalin-fixed, paraffin-embedded tissues: protein digestion as a limiting step for retrieval of high-quality DNA.

Authors:  S J Díaz-Cano; S P Brady
Journal:  Diagn Mol Pathol       Date:  1997-12

3.  Evidence for monoclonal expansion of epithelial cells in ovarian endometrial cysts.

Authors:  H Jimbo; Y Hitomi; H Yoshikawa; T Yano; M Momoeda; A Sakamoto; O Tsutsumi; Y Taketani; H Esumi
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

4.  Clonal analysis of focal nodular hyperplasia of the liver.

Authors:  M J Gaffey; J C Iezzoni; L M Weiss
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

5.  Genetic analysis of benign, low-grade, and high-grade ovarian tumors.

Authors:  H Iwabuchi; M Sakamoto; H Sakunaga; Y Y Ma; M L Carcangiu; D Pinkel; T L Yang-Feng; J W Gray
Journal:  Cancer Res       Date:  1995-12-15       Impact factor: 12.701

Review 6.  DNA flow cytometry in solid tumors: practical aspects and clinical applications.

Authors:  L G Dressler; S A Bartow
Journal:  Semin Diagn Pathol       Date:  1989-02       Impact factor: 3.464

7.  Clonal analysis of solitary follicular nodules in the thyroid.

Authors:  D G Hicks; V A LiVolsi; J A Neidich; J M Puck; J A Kant
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

8.  Nuclear DNA patterns in adrenal cortex proliferative lesions.

Authors:  S Díaz-Cano; R González-Cámpora; J J Ríos-Martín; E Lerma-Puertas; M Jordà-Heras; F Vázquez-Ramírez; M Bibbo; H Galera-Davidson
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 9.  Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators.

Authors:  B W Stewart
Journal:  J Natl Cancer Inst       Date:  1994-09-07       Impact factor: 13.506

Review 10.  Role of programmed cell death in carcinogenesis.

Authors:  J T Isaacs
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

View more
  8 in total

1.  Clonal origin and expansions in neoplasms: biologic and technical aspects must be considered together.

Authors:  Lucia Pozo-Garcia; Salvador J Diaz-Cano
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

2.  Irregular and frequent cortisol secretory episodes with preserved diurnal rhythmicity in primary adrenal Cushing's syndrome.

Authors:  M O van Aken; A M Pereira; S W van Thiel; G van den Berg; M Frölich; J D Veldhuis; J A Romijn; F Roelfsema
Journal:  J Clin Endocrinol Metab       Date:  2004-12-14       Impact factor: 5.958

Review 3.  Aberrant expression of hormone receptors in adrenal Cushing's syndrome.

Authors:  Stavroula Christopoulos; Isabelle Bourdeau; André Lacroix
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

Review 4.  Progress in primary aldosteronism: present challenges and perspectives.

Authors:  C E Gomez-Sanchez; G P Rossi; F Fallo; M Mannelli
Journal:  Horm Metab Res       Date:  2010-01-20       Impact factor: 2.936

Review 5.  Adrenal histopathology in primary aldosteronism: is it time for a change?

Authors:  Francesca Gioco; Teresa Maria Seccia; Elise P Gomez-Sanchez; Gian Paolo Rossi; Celso E Gomez-Sanchez
Journal:  Hypertension       Date:  2015-08-03       Impact factor: 10.190

Review 6.  Mouse models of adrenocortical tumors.

Authors:  Kaitlin J Basham; Holly A Hung; Antonio M Lerario; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2015-12-08       Impact factor: 4.102

Review 7.  New concepts in adrenal vein sampling for aldosterone in the diagnosis of primary aldosteronism.

Authors:  Gian Paolo Rossi
Journal:  Curr Hypertens Rep       Date:  2007-04       Impact factor: 4.592

Review 8.  Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design.

Authors:  Salvador J Diaz-Cano
Journal:  Int J Mol Sci       Date:  2012-02-13       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.